[1] |
Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang.
Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354.
|
[2] |
Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong.
The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65.
|
[3] |
Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing.
Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909.
|
[4] |
Geng Junling, Zhang Yinan, Pan Hongqiu.
Establishment and validation of a risk prediction model for drug-induced liver injury in patients with tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 699-706.
|
[5] |
Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao.
Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402.
|
[6] |
You Enqing, Li Juan, Chen Lili, Liu Wei, Wu Jinju, Cao Hong.
Influence of meteorological factors on the incidence of pulmonary tuberculosis in Hefei City from 2013 to 2022
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 349-356.
|
[7] |
Song Yuanyuan, Li Tao, Xia Hui, Zhang Lijie, Zhang Hui, Zhao Yanlin, Wang Lixia.
Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1198-1208.
|
[8] |
Du Yongcheng, Lin Shufang, Dai Zhisong, Lin Jian.
Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Fujian Province from 2008 to 2022
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1219-1226.
|
[9] |
Kong Hanhan, Zhang Jiaohong, Zeng Jianfeng, Cao Jing.
Construction and validation of frailty risk prediction model in elderly patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 85-91.
|
[10] |
Zhou Wenyong, Wen Zexuan, Gao Mengxian, Li Tao, Zhang Hui, Wang Weibing.
Prediction of the effectiveness and impact of the free healthcare policy for tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 845-856.
|
[11] |
Ren Feilin, Liu Xiaoqi, Jin Meihua, Sun Xiuxiu.
Study on the predictive effect of seasonal auto regressive integrated moving average model on the incidence of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 514-519.
|
[12] |
Mao Hongkai, Zhang Yan, Liang Zhichao, Xia Wenjun, Bao Liangliang, Mayisha·Daken , Wang Xiaomin, Cao Mingqin.
Evaluation of implementation effect of pulmonary tuberculosis prevention and control strategy in southern Xinjiang based on synthetic control method
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 383-390.
|
[13] |
Liu Simin, Li Qiaomei, Tang Jiayi, Li Tingting, Ding Guowu.
Analysis of trend in tuberculosis incidence among people aged 0-10 years in China based on an age-period-cohort model
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 181-187.
|
[14] |
Sun Minghao, Duan Yuqi, Zheng Liang, Yu Shengnan, Cheng Chuanlong, Zuo Hui, Chen Ming, Li Xiujun.
Application of ARIMA, ARIMAX, and NGO-LSTM models in forecasting the incidence of tuberculosis cases in Liaocheng City, Shandong Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1177-1185.
|
[15] |
Chen Daiquan, Lin Shufang, Dai Zhisong, Zhou Yinfa, Chen Kun.
Construction and validation of a nomogram for predicting unfavorable treatment outcomes among patients with rifampicin-sensitive tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(10): 957-966.
|